7,765 Shares in iShares Biotechnology ETF $IBB Bought by Global View Capital Management LLC

Global View Capital Management LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 7,765 shares of the financial services provider’s stock, valued at approximately $1,635,000.

A number of other institutional investors have also added to or reduced their stakes in the business. IFP Advisors Inc increased its position in shares of iShares Biotechnology ETF by 39.3% in the second quarter. IFP Advisors Inc now owns 49,988 shares of the financial services provider’s stock worth $9,507,000 after purchasing an additional 14,115 shares during the last quarter. Security National Bank of Sioux City Iowa IA lifted its holdings in shares of iShares Biotechnology ETF by 31.8% during the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 12,187 shares of the financial services provider’s stock worth $2,318,000 after acquiring an additional 2,939 shares during the last quarter. Kestra Advisory Services LLC grew its position in iShares Biotechnology ETF by 12.2% in the first quarter. Kestra Advisory Services LLC now owns 47,461 shares of the financial services provider’s stock worth $8,014,000 after acquiring an additional 5,155 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in iShares Biotechnology ETF by 64.0% in the second quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock worth $19,369,000 after acquiring an additional 39,760 shares in the last quarter. Finally, Navellier & Associates Inc. purchased a new position in iShares Biotechnology ETF in the second quarter worth $531,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

IBB opened at $217.61 on Friday. iShares Biotechnology ETF has a 52 week low of $154.62 and a 52 week high of $222.29. The business’s fifty day simple moving average is $208.43 and its 200 day simple moving average is $184.81.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were issued a $0.0112 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.0%. The ex-dividend date was Tuesday, September 15th. This is a decrease from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.